SCHEMBL7991686

SCHEMBL7991686

CNCc1nc(=O)c2c(ncn2Cc2ccc(C(C)(C)C)cc2)[nH]1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABCC8 Q09428 1/20 0.48
KCNJ11 Q14654 1/20 0.48
CNOT7 Q9UIV1 3/20 0.39
PARN O95453 1/20 0.39
NR1H4 Q96RI1 5/20 0.36
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
MAP3K5 Q99683 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
NR1I2 O75469 1/20 0.34
ADORA2B P29275 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
HPGD P15428 1/20 0.33
F2R P25116 1/20 0.33
METAP2 P50579 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7985467 0.99 ABCC8 (0.47) ABCC8KCNJ11CNOT7PARNNR1H4
SCHEMBL7984470 0.89 ABCC8 (0.50) ABCC8KCNJ11CNOT7PARNNR1H4
SCHEMBL7988039 0.87 CNOT7 (0.41) CNOT7PARNLMNAMAPK1MEN1
SCHEMBL7984748 0.87 ABCC8 (0.48) ABCC8KCNJ11CNOT7PARNNR1H4
Hydrochloric Acid SCHEMBL7988145 0.86 CNOT7 (0.40) CNOT7PARNLMNAMAPK1MEN1
SCHEMBL7985516 0.86 CNOT7 (0.40) CNOT7PARNLMNAMEN1KMT2A
SCHEMBL7984366 0.86 CNOT7 (0.53) CNOT7PARNKMT2AADORA2BSMN1; SMN2
SCHEMBL7985645 0.86 ABCC8 (0.47) ABCC8KCNJ11CNOT7PARNNR1H4
Hydrochloric Acid SCHEMBL7988733 0.85 CNOT7 (0.40) CNOT7PARNLMNAMEN1KMT2A
Hydrochloric Acid SCHEMBL7992068 0.85 CNOT7 (0.52) CNOT7PARNKMT2AADORA2BSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed